PPAR-sparing thiazolidinedione salts for the treatment of metabolic diseases

Details for Australian Patent Application No. 2010340055 (hide)

Owner Metabolic Solutions Development Company, LLC

Inventors Colca, Gerard R.; Tanis, Steven P.; Larsen, Scott D.

Agent Spruson & Ferguson

Pub. Number AU-A-2010340055

PCT Pub. Number WO2011/084453

Priority 61/286,765 15.12.09 US

Filing date 15 December 2010

Wipo publication date 14 July 2011

International Classifications

C07D 277/34 Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

A61K 31/426 - 1,3-Thiazoles

A61K 31/4439

A61P 3/00 Drugs for disorders of the metabolism

A61P 5/00 Drugs for disorders of the endocrine system

C07D 417/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

28 June 2012 PCT application entered the National Phase

  PCT publication WO2011/084453 Priority application(s): WO2011/084453

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010340058-PPAR-sparing thiazolidinediones and combinations for the treatment of diabetes mellitus and other metabolic diseases

2010340050-Non-porous moisture and gas permeable films